The Latest Breaking News from Colossal Biosciences

Researchers working with Colossal Biosciences have assembled a near-complete Tasmanian tiger genome and developed artificial reproductive technologies that could help de-extinct the species.

Director Peter Jackson has given $10m to a startup aiming to revive extinct animals, writes Arwa Mahdawi. Did he learn nothing from Jurassic Park?

Colossal Biosciences explain the complex science behind ‘de-extinction’ and reveal their target date for the first woolly mammoth calf.

"This is probably the most significant step in the early stages of this project," said George Church, a geneticist at Harvard University. The post “I’ve Seen Jurassic Park”: Skepticism After Biotech Firm Edges Closer To Resurrecting Mammoths first appeared on Bored Panda.

Colossal Biosciences advances in de-extincting woolly mammoth through reprogrammed elephant stem cells.

Scientists at the company Colossal Biosciences have derived induced pluripotent stem cells from elephants, which they say could boost efforts to resurrect woolly mammoths.

Explore the groundbreaking work of Colossal Biosciences in genetically resurrecting extinct species in a documentary series by James Reed.

Colossal Biosciences, which is behind bid to bring back Tasmanian tiger, teams up with Melbourne Zoo to save 15cm reptile

Jurassic Park, the 1993 film about dinosaurs, is a cultural tour de force. Not only did the film herald a new era in computer-generated movie effects, it also revived the field of paleontology. And if that wasn’t enough, it raised questions about the ethics of DNA research.